Literature DB >> 326163

Immunologic aspects of cancer chemotherapy.

C M Haskell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326163     DOI: 10.1146/annurev.pa.17.040177.001143

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  8 in total

1.  Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer.

Authors:  Yiqing Xu; Nanda Methuku; Praveena Coimbatore; Theresa Fitzgerald; Yiwu Huang; Ying-Yi Xiao; Murali Pagala; Shachi Gupta; William Solomon; Philip Rubin; John Treanor; Alan Astrow; Howard Minkoff; Jay S Cooper
Journal:  Oncologist       Date:  2012-01-12

2.  Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.

Authors:  M Gereis; A P Burford-Mason; S M Watkins
Journal:  Agents Actions       Date:  1987-12

3.  Experimental inflammation and tumor growth: chemical carcinogenesis in adjuvant arthritic rats.

Authors:  P Görög; I B Kovács
Journal:  Inflammation       Date:  1979-09       Impact factor: 4.092

4.  Immunological monitoring of patients affected by anaplastic glioma concerning in effects of surgery, radio-, and chemotherapy. A preliminary report.

Authors:  F Servadei; R Parente; F Spagnolli; G Gaist; R Padovani; M Bucci; L Steiner
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

5.  The antitumor activity and immunosuppressive effects of 5-fluorouracil suppositories in rectal cancer patients.

Authors:  W Adachi; A Sugenoya; N Horigome; C Takahashi; F Iida; J Nakayama
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

6.  Modulation of the immune response to tumors by a novel synthetic compound, (4R)-3-benzoyl-N-[(1R)-1-phenylethyl]-4-thiazolidinecarboxamide (RS-0481).

Authors:  S Kurakata; M Tomatsu; M Arai; H Arai; A Hishinuma; H Kohno; K Kitamura; T Kobayashi; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Harmful effects of i.v. Corynebacterium Parvum given at the same time as cyclophosphamide in patients with squamous-cell carcinoma of the bronchus.

Authors:  B M von Blomberg; J Glerum; J J Croles; J Stam; H A Drexhage
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

Review 8.  Medicinal Plants from Mexico, Central America, and the Caribbean Used as Immunostimulants.

Authors:  Angel Josabad Alonso-Castro; María Del Carmen Juárez-Vázquez; Nimsi Campos-Xolalpa
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-03       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.